Tenax Therapeutics (TENX)
(Delayed Data from NSDQ)
$3.81 USD
+0.12 (3.25%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $3.81 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -1.32 |
EPS Last Quarter | -1.83 |
Last EPS Surprise | 8.04% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.68 |
Next Year | -2.39 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.32 | -1.40 | -6.68 | -2.39 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -1.47 | -1.66 | -7.35 | -3.89 |
High Estimate | -1.16 | -1.14 | -6.01 | -0.89 |
Low Estimate | -1.47 | -1.66 | -7.35 | -3.89 |
Year ago EPS | -6.40 | NA | -31.04 | -6.68 |
Year over Year Growth Est. | 79.38% | NA | 78.48% | 64.22% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.32 | -1.40 | -6.68 | -2.39 |
7 Days Ago | -1.32 | -1.40 | -6.68 | -2.39 |
30 Days Ago | -1.38 | -1.43 | -6.87 | -1.42 |
60 Days Ago | -2.03 | -1.57 | -7.96 | -3.72 |
90 Days Ago | -2.03 | -1.57 | -7.96 | -3.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.32 | -1.40 | -6.68 | -2.39 |
Zacks Consensus Estimate | -1.32 | -1.40 | -6.68 | -2.39 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.83 | -3.12 | NA | -6.40 | NA |
Estimate | -1.99 | -2.40 | NA | -7.20 | NA |
Difference | 0.16 | -0.72 | NA | 0.80 | 0.08 |
Surprise | 8.04% | -30.00% | NA | 11.11% | -3.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more